Growth Metrics

DiaMedica Therapeutics (DMAC) Short term Debt (2017)

DiaMedica Therapeutics filings provide 1 years of Short term Debt readings, the most recent being $84000.0 for Q4 2017.

  • Quarterly Short term Debt changed N/A to $84000.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $84000.0 through Dec 2017, changed N/A year-over-year, with the annual reading at $84000.0 for FY2017, N/A changed from the prior year.
  • Short term Debt hit $84000.0 in Q4 2017 for DiaMedica Therapeutics.
  • Across five years, Short term Debt topped out at $84000.0 in Q4 2017 and bottomed at $84000.0 in Q4 2017.